Does the Strategy of Risk Group Testing for Hepatitis C Hit the Target?

In the European Union, it is estimated that there are 5.5 million individuals with chronic infection of hepatitis C. Intravenous drug abuse is undoubtedly the key source of the hepatitis C epidemic in Europe and the most efficient mode of transmission of HCV infections (primarily due to short incuba...

Descripción completa

Detalles Bibliográficos
Autores principales: Jovanovic, Mirjana R., Miljatovic, Aleksandar, Puskas, Laslo, Kapor, Slobodan, Puskas, Dijana L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492802/
https://www.ncbi.nlm.nih.gov/pubmed/28713277
http://dx.doi.org/10.3389/fphar.2017.00437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492802/
https://www.ncbi.nlm.nih.gov/pubmed/28713277
http://dx.doi.org/10.3389/fphar.2017.00437

Ejemplares similares